ng-nitroarginine methyl ester has been researched along with Neurodegenerative Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Hong, JS; Kadiiska, MB; Kalyanaraman, B; Kumar, A; Mason, RP; Zielonka, J | 1 |
| Graber, DJ; Lawrence, DA; Snyder-Keller, A; Turner, JN | 1 |
| da Rocha, RF; de Oliveira, MR; Moreira, JC; Schnorr, CE | 1 |
| Agarwal, AK; Chaturvedi, RK; Das, T; Dikshit, M; Ravindran, A; Shukla, Y; Singh, S | 1 |
| Cui, H; Lau, AC; Tymianski, M | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Neurodegenerative Diseases
| Article | Year |
|---|---|
The use of propidium iodide to assess excitotoxic neuronal death in primary mixed cortical cultures.
Topics: Acute Disease; Animals; Benzimidazoles; Brain Ischemia; Cell Death; Cells, Cultured; Cerebral Cortex; Drug Evaluation, Preclinical; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Humans; Immunohistochemistry; Indicators and Reagents; Mice; Microscopy, Fluorescence; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Propidium; Receptors, N-Methyl-D-Aspartate | 2007 |
4 other study(ies) available for ng-nitroarginine methyl ester and Neurodegenerative Diseases
| Article | Year |
|---|---|
Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells.
Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Boronic Acids; Cell Line, Transformed; Coumarins; Enzyme Inhibitors; Free Radicals; Imidazoles; Lipopolysaccharides; Metalloporphyrins; Mice; Microglia; Neurodegenerative Diseases; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Proline; Pyridines; RNA Interference; RNA, Small Interfering; Spin Trapping; Thiocarbamates | 2014 |
Neurodegeneration by activated microglia across a nanofiltration membrane.
Topics: Animals; Cell Survival; Cells, Cultured; Cellulose; Coculture Techniques; Dopaminergic Neurons; Lipopolysaccharides; Membranes, Artificial; Mesencephalon; Microglia; Neurodegenerative Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2012 |
L-NAME cotreatment did prevent neither mitochondrial impairment nor behavioral abnormalities in adult Wistar rats treated with vitamin A supplementation.
Topics: alpha-Synuclein; Animals; Anxiety Disorders; Behavior, Animal; Central Nervous System; Dietary Supplements; Diterpenes; Electron Transport; Glutathione Transferase; Heat-Shock Proteins; Illness Behavior; Locomotion; Male; Manganese; Mitochondria; Monoamine Oxidase; Neurodegenerative Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidation-Reduction; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Dopamine; Receptors, Immunologic; Retinyl Esters; Superoxide Dismutase; Superoxides; Tyrosine; Vitamin A | 2012 |
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease.
Topics: Animals; Brain; Female; Lipopolysaccharides; Male; Neurodegenerative Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2005 |